TruNorth Capital Management LLC Trims Stock Position in The Clorox Company (NYSE:CLX)

TruNorth Capital Management LLC decreased its position in shares of The Clorox Company (NYSE:CLX) by 22.0% during the 4th quarter, HoldingsChannel.com reports. The firm owned 298 shares of the company’s stock after selling 84 shares during the quarter. TruNorth Capital Management LLC’s holdings in Clorox were worth $48,000 as of its most recent filing with the SEC.

Other hedge funds also recently made changes to their positions in the company. Brooklyn Investment Group grew its stake in Clorox by 163.8% during the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after buying an additional 95 shares during the last quarter. Prospera Private Wealth LLC acquired a new stake in shares of Clorox in the third quarter valued at approximately $27,000. Continuum Advisory LLC grew its position in shares of Clorox by 300.0% during the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after acquiring an additional 138 shares during the last quarter. Asset Planning Inc acquired a new position in shares of Clorox in the 4th quarter valued at $32,000. Finally, BankPlus Trust Department acquired a new position in shares of Clorox in the 4th quarter valued at $40,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Stock Down 1.7 %

Shares of CLX opened at $154.52 on Tuesday. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.37. The company’s fifty day moving average is $157.53 and its two-hundred day moving average is $160.03. The firm has a market cap of $19.03 billion, a PE ratio of 42.22, a price-to-earnings-growth ratio of 2.62 and a beta of 0.42. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52.

Clorox (NYSE:CLX) last issued its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period in the previous year, the company earned $2.16 EPS. Analysts forecast that The Clorox Company will post 7.15 earnings per share for the current year.

Analysts Set New Price Targets

Several brokerages have issued reports on CLX. JPMorgan Chase & Co. raised their price objective on shares of Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 4th. DA Davidson dropped their price target on Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 5th. StockNews.com downgraded Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. Wells Fargo & Company lifted their target price on Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 4th. Finally, TD Cowen upgraded Clorox from a “sell” rating to a “hold” rating and upped their price target for the stock from $155.00 to $170.00 in a research note on Wednesday, November 6th. Four investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has issued a buy rating to the company. According to data from MarketBeat.com, Clorox presently has a consensus rating of “Hold” and a consensus price target of $158.21.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.